PCOS Renamed PMOS to Reflect Wider Symptoms
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) about two months ago to better capture symptoms beyond ovarian cysts and to allow for a possible male form of the condition.
- Women of color experience double the prevalence of PMOS compared to white women; Black women face more severe hirsutism and hypertension, while Hispanic and Latina women face more severe metabolic complications, plus delayed diagnosis and low insurance coverage.
- More than 5 million women and girls of reproductive age in the US live with PMOS, and the World Health Organization estimates up to 70% of cases globally are undiagnosed.
- PMOS diagnosis uses exclusion-based criteria—physicians check for two of three: irregular or absent ovulation, hyperandrogenism, or ovaries with an accumulation of small follicles—with no single confirmatory test.
- More than one-third of physicians wrongly associate "cysts on ovaries" with PMOS, even though only about a quarter of patients present with extra follicles, a longstanding miseducation the source said delayed diagnosis.
- Margaret Lippincott, director of the Multidisciplinary Care Center for PMOS at Massachusetts General Hospital, said obesity is not and has never been part of the diagnostic criteria, noting many women have high fasting insulin regardless of weight.
- Andrea Medina-Alvarado of the National Latina Institute for Reproductive Justice warned that Medicaid access losses expected under the One Big Beautiful Bill Act and ICE raids are keeping immigrant communities afraid to leave home for groceries or health care.
Why it matters: With up to 70% of PMOS cases undiagnosed globally and more than one-third of physicians anchoring on the old "cysts on ovaries" framing, the rename is an overdue correction that still depends on retraining clinicians. Black and Latina women—already facing doubled prevalence and delayed diagnosis—will absorb the impact first as Medicaid cuts under the One Big Beautiful Bill Act and ICE-driven fear further restrict their access to care.
